Information:
Fel:
ID
32627
Beskrivning
Comparing the Metabolic Control of Once to Twice-daily Insulin Detemir Injections; ODM derived from: https://clinicaltrials.gov/show/NCT00542399
Länk
https://clinicaltrials.gov/show/NCT00542399
Nyckelord
Versioner (1)
- 2018-11-08 2018-11-08 -
Rättsinnehavare
See clinicaltrials.gov
Uppladdad den
8 november 2018
DOI
För en begäran logga in.
Licens
Creative Commons BY 4.0
Modellkommentarer :
Här kan du kommentera modellen. Med hjälp av pratbubblor i Item-grupperna och Item kan du lägga in specifika kommentarer.
Itemgroup-kommentar för :
Item-kommentar för :
Du måste vara inloggad för att kunna ladda ner formulär. Var vänlig logga in eller registrera dig utan kostnad.
Eligibility Type 1 Diabetes Mellitus NCT00542399
Eligibility Type 1 Diabetes Mellitus NCT00542399
- StudyEvent: Eligibility
Similar models
Eligibility Type 1 Diabetes Mellitus NCT00542399
- StudyEvent: Eligibility
Name
Typ
Description | Question | Decode (Coded Value)
Datatyp
Alias
Informed Consent
Item
1. informed consent obtained before any trial related activity
boolean
C0021430 (UMLS CUI [1])
Children | Diabetes Mellitus, Insulin-Dependent | Insulin regime
Item
2. children with type 1 diabetes who have been treated with insulin for at least 12 months prior to the study.
boolean
C0008059 (UMLS CUI [1])
C0011854 (UMLS CUI [2])
C0557978 (UMLS CUI [3])
C0011854 (UMLS CUI [2])
C0557978 (UMLS CUI [3])
Age
Item
3. age > 6 years and < 18 years
boolean
C0001779 (UMLS CUI [1])
Hemoglobin A1c measurement
Item
4. hba1c > 7.7%
boolean
C0474680 (UMLS CUI [1])
Protocol Compliance | Insulin detemir Injection
Item
5. ability and willingness to accept the study conditions and to inject insulin detemir
boolean
C0525058 (UMLS CUI [1])
C0537270 (UMLS CUI [2,1])
C1828121 (UMLS CUI [2,2])
C0537270 (UMLS CUI [2,1])
C1828121 (UMLS CUI [2,2])
Renal Insufficiency | Dialysis procedure
Item
1. impaired renal function or current renal dialysis.
boolean
C1565489 (UMLS CUI [1])
C0011946 (UMLS CUI [2])
C0011946 (UMLS CUI [2])
Metabolic acidosis | Chronic metabolic acidosis | Diabetic Ketoacidosis
Item
2. acute or chronic metabolic acidosis, including diabetic ketoacidosis.
boolean
C0220981 (UMLS CUI [1])
C0740749 (UMLS CUI [2])
C0011880 (UMLS CUI [3])
C0740749 (UMLS CUI [2])
C0011880 (UMLS CUI [3])
Hypoglycemia unawareness.
Item
3. known hypoglycemia unawareness.
boolean
C0342317 (UMLS CUI [1])
Hypersensitivity Investigational New Drugs | Hypersensitivity Suspected Investigational New Drugs
Item
4. known or suspected allergy to trial products.
boolean
C0020517 (UMLS CUI [1,1])
C0013230 (UMLS CUI [1,2])
C0020517 (UMLS CUI [2,1])
C0750491 (UMLS CUI [2,2])
C0013230 (UMLS CUI [2,3])
C0013230 (UMLS CUI [1,2])
C0020517 (UMLS CUI [2,1])
C0750491 (UMLS CUI [2,2])
C0013230 (UMLS CUI [2,3])
Liver diseases | Liver Dysfunction
Item
5. clinical evidence of active liver disease or impaired hepatic function
boolean
C0023895 (UMLS CUI [1])
C0086565 (UMLS CUI [2])
C0086565 (UMLS CUI [2])
Study Subject Participation Status | Investigational New Drugs
Item
6. participation in another study (with study drug) within the last 3 months prior to this trial.
boolean
C2348568 (UMLS CUI [1])
C0013230 (UMLS CUI [2])
C0013230 (UMLS CUI [2])
Comorbidity Interferes with Glucose metabolism
Item
7. significant concomitant disease likely to interfere with glucose metabolism
boolean
C0009488 (UMLS CUI [1,1])
C0521102 (UMLS CUI [1,2])
C0596620 (UMLS CUI [1,3])
C0521102 (UMLS CUI [1,2])
C0596620 (UMLS CUI [1,3])
Eating Disorders
Item
8. proven eating disorders
boolean
C0013473 (UMLS CUI [1])
Malignant Neoplasms
Item
9. malignancy within the last 5 years
boolean
C0006826 (UMLS CUI [1])
Hypoglycemia Severe Repeated
Item
10. history of repeated severe hypoglycemia within the last year.
boolean
C0020615 (UMLS CUI [1,1])
C0205082 (UMLS CUI [1,2])
C0205341 (UMLS CUI [1,3])
C0205082 (UMLS CUI [1,2])
C0205341 (UMLS CUI [1,3])
Diabetic Retinopathy
Item
11. known diabetes retinopathy
boolean
C0011884 (UMLS CUI [1])